RegenMed Asia

RegenMed Asia is a biotechnology company based in Bangkok, Thailand, specializing in the development and delivery of regenerative medicine solutions. The company operates a certified GMP facility dedicated to the isolation, expansion, and characterization of Mesenchymal Stem Cells (MSCs) and their derivatives, such as exosomes. RegenMed Asia provides a range of services including cell banking, contract development and manufacturing (CDMO), and clinical protocol development for various therapeutic areas including orthopedics and aesthetics. By integrating advanced cellular technology with clinical expertise, the company aims to provide accessible and effective regenerative treatments across the Asia-Pacific region. Their core focus involves bridging the gap between laboratory research and clinical application to treat chronic conditions like osteoarthritis and autoimmune disorders.